Cargando…

IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome

Detalles Bibliográficos
Autores principales:	Dufranc, Etienne, Del Bello, Arnaud, Belliere, Julie, Kamar, Nassim, Faguer, Stanislas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175448/ https://www.ncbi.nlm.nih.gov/pubmed/32321563 http://dx.doi.org/10.1186/s13054-020-02878-7

Ejemplares similares

Predictive Factors for Humoral Response After 2-dose SARS-CoV-2 Vaccine in Solid Organ Transplant Patients
por: Marion, Olivier, et al.
Publicado: (2021)

Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy
por: Medrano, Chloé, et al.
Publicado: (2019)

Apolipoprotein-A-I for severe COVID-19-induced hyperinflammatory states: A prospective case study
por: Faguer, Stanislas, et al.
Publicado: (2022)

Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients
por: Kamar, Nassim, et al.
Publicado: (2022)

Hemodynamic and Metabolic Tolerance of Acetate-Free Biofiltration in Mechanically Ventilated Critically Ill Patients: A Real-Life Study
por: Gouin, Anna, et al.
Publicado: (2021)

Spectrum of Kidney Disorders Associated with T-Cell Immunoclones
por: Piedrafita, Alexis, et al.
Publicado: (2022)

Adaptive lymphocyte profile analysis discriminates mild and severe forms of COVID-19 after solid organ transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2021)

Beneficial Effect of Conversion to Belatacept in Kidney-Transplant Patients with a Low Glomerular-Filtration Rate
por: Belliere, Julie, et al.
Publicado: (2014)

Hemophagocytic syndrome in the critically ill
por: Rokyta, R., et al.
Publicado: (2000)

Outcomes of kidney transplant recipients admitted to the intensive care unit: a retrospective study of 200 patients
por: Guinault, Damien, et al.
Publicado: (2019)

High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2018)

Facteurs prédictifs de réponse vaccinale anti-SARS-CoV2 chez les transplantés d’organes solides : une étude rétrospective monocentrique
por: Marion, O., et al.
Publicado: (2021)

Acetate-Free Biofiltration Versus Online Acetate-Free Hemodiafiltration in Patients at High Risk of Hemodialysis Intolerance
por: Apter, Clara, et al.
Publicado: (2022)

Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine
por: Abravanel, Florence, et al.
Publicado: (2022)

UMOD genetic variations and myeloma cast nephropathy
por: Belliere, Julie, et al.
Publicado: (2019)

Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory?
por: Medrano, Chloé, et al.
Publicado: (2021)

Acute interstitial nephritis related to immune checkpoint inhibitors
por: Belliere, Julie, et al.
Publicado: (2016)

Possible patient to patient transmission of progressive multifocal leukoencephalopathy among kidney-transplant patients
por: Lajaunie, Rebecca, et al.
Publicado: (2020)

Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?
por: Del Bello, Arnaud, et al.
Publicado: (2022)

Les anticorps monoclonaux anti-SARS-CoV-2 sont efficaces pour éviter les formes graves de COVID-19 chez le transplanté d’organe solide
por: Del Bello, A., et al.
Publicado: (2021)

Coagulation Disorders and Bleedings in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis
por: Valade, Sandrine, et al.
Publicado: (2015)

The CD226/TIGIT axis is involved in T cell hypo-responsiveness appearance in long-term kidney transplant recipients
por: Del Bello, Arnaud, et al.
Publicado: (2022)

Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients
por: Del Bello, Arnaud, et al.
Publicado: (2022)

Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients
por: Kamar, Nassim, et al.
Publicado: (2022)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

Tocilizumab in critically ill COVID-19 patients: An observational study
por: Mushtaq, Muhammad Z., et al.
Publicado: (2022)

Ibrutinib does not prevent kidney fibrosis following acute and chronic injury
por: Belliere, Julie, et al.
Publicado: (2021)

Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells
por: Lokau, Juliane, et al.
Publicado: (2020)

Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19
por: Yang, Kun, et al.
Publicado: (2021)

Incidence of Secondary Hemophagocytic Lymphohistiocytosis in Critically-Ill COVID-19 Patients
por: Allen, Jamie, et al.
Publicado: (2021)

Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients
por: Bhandari, Sudhir, et al.
Publicado: (2021)

Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates
por: Mehawej, Mireille, et al.
Publicado: (2015)

ABO-Incompatible Robotic-Assisted Kidney Transplantation in the Obese Recipient
por: Prudhomme, Thomas, et al.
Publicado: (2020)

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
por: Kamar, Nassim, et al.
Publicado: (2021)

Avacopan as First-Line Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Steroid-Sparing Option
por: Gabilan, Charlotte, et al.
Publicado: (2022)

Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report
por: Tholin, Birgitte, et al.
Publicado: (2020)

The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill
por: Knight, Jennifer M., et al.
Publicado: (2021)

Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies
por: Gouin, Anna, et al.
Publicado: (2021)

Acute rejection after anti–SARS-CoV-2 mRNA vaccination in a patient who underwent a kidney transplant
por: Del Bello, Arnaud, et al.
Publicado: (2021)

The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
por: Zacharias, Harry, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rd33n2ef2bnf1g20s85c01eiqr